Concepedia

Guoquan Wan

GW

Statistics

Publications

6

Citations

134

H-Index

6

Active since

2019

Affiliations

State Key Laboratory of Biotherapy(Current)

Sichuan University

Southwest Jiaotong University

Chengdu Normal University

Chengdu University

Guoquan Wan is an author at State Key Laboratory of Biotherapy specializing in drug discovery, drug design, and medicinal chemistry.

Publications per year

2019–2023

6

Publications

6

Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Cancer

Guoquan Wan, Zhanzhan Feng, Qiangsheng Zhang et al. · Journal of Medicinal Chemistry · 2022 · 28 citations · Full text

, , +12

Design, synthesis and biological evaluations of a series of Pyrido[1,2-a]pyrimidinone derivatives as novel selective FGFR inhibitors

Kai Ran, Jun Zeng, Guoquan Wan et al. · European Journal of Medicinal Chemistry · 2021 · 27 citations · Full text

, , +13

Discovery of a Novel Covalent EZH2 Inhibitor Based on Tazemetostat Scaffold for the Treatment of Ovarian Cancer

Qiangsheng Zhang, Xinyi Chen, Jiaying Cao et al. · Journal of Medicinal Chemistry · 2023 · 24 citations · Full text

, , +17

Covalent inhibitors of EZH2: Design, synthesis and evaluation

Qiangsheng Zhang, Xinyi Chen, Xi Hu et al. · Biomedicine & Pharmacotherapy · 2022 · 21 citations · Full text

, , +17

Discovery of 3-(((9H-purin-6-yl)amino)methyl)-4,6-dimethylpyridin-2(1H)-one derivatives as novel tubulin polymerization inhibitors for treatment of cancer

Qiangsheng Zhang, Xi Hu, Guoquan Wan et al. · European Journal of Medicinal Chemistry · 2019 · 17 citations

, , +12

1–5 of 6